Matthew Horsman serves as as Senior Controller of AVEO Oncology, an LG Chem company. With an accounting career spanning over 25 years, Mr. Horsman has held various accounting roles across multiple industries. Prior to joining AVEO’s management team, he served as the Controller for Enzyvant Therapeutics, Inc. During Mr. Horsman’s time at Enzyvant, he oversaw several finance enhancement projects, Enzyvant’s conversion from US GAAP to international financial reporting standards and was responsible for accounting activities related to the merger between Enzyvant and Altavant Sciences, Inc. 

Mr. Horsman holds a Bachelor of Science degree in Accounting from Stonehill College and a Masters of Business from Curry College. He is a licensed CPA in the state of Massachusetts. Mr. Horsman also has completed an international financial reporting standards certificate program with the American Institute of Certified Public Accountants.